Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
3 Stocks with Jaw-Dropping Growth Potential
10:00am, Monday, 23'rd Nov 2020
Aprea Therapeutics, Viking Therapeutics, and Vaxart could all generate life-changing returns for early shareholders.
Where Will Vaxart Be in 1 Year?
07:04am, Saturday, 21'st Nov 2020
Large-cap coronavirus vaccine stocks are making investors rich. Can this small biotech do so as well?
Vaxart Hosting Key Opinion Leader Panel Call for Investors
08:30am, Monday, 16'th Nov 2020
Title: An Oral Tablet Vaccine – A Potential Global Solution to COVID-19 and Norovirus
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than
Vaxart Reports Third Quarter 2020 Financial Results and Provides Business Update
04:01pm, Thursday, 12'th Nov 2020
Enrollment in Phase 1 for Oral COVID-19 Vaccine Trial Completed
7 Biotech Penny Stocks Worth a Gamble
11:50am, Wednesday, 11'th Nov 2020
With the pandemic drawing much attention toward biotech stocks, there are some interesting ideas among in the small-cap field, but only if you understand the severe risks involved. The post 7 Biotech
How to Invest in the Coronavirus Vaccine Race Right Now
06:53am, Wednesday, 11'th Nov 2020
Pfizer grabbed the spotlight when it released efficacy data from its phase 3 study earlier this week. But is it too late to get in on the action?
Why Inovio Pharmaceuticals, Novavax, and Vaxart Crashed in October
10:00am, Monday, 09'th Nov 2020
These three pre-revenue COVID-19 vaccine stocks took a beating last month.
These 2 Coronavirus Vaccine Stocks Could Be Game-Changers
07:06am, Friday, 06'th Nov 2020
These companies won't cross the finish line first. But if and when they do, they're sure to grab market share.
Avoid These 2 Coronavirus Innovator Stocks in November
06:25am, Wednesday, 04'th Nov 2020
These companies aren't about to win the coronavirus vaccine race, but their competitors probably will.
NEW YORK, Oct. 16, 2020 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), an international securities and consumer rights litigation firm, reminds investors that class action lawsuits
San Francisco, California--(Newsfile Corp. - October 15, 2020) - Hagens Berman announces that it has filed a class action lawsuit against Vaxart, Inc. (NASDAQ: VXRT) and certain of its senior executiv
Vaxart (VXRT) Begins Dosing in Oral Coronavirus Vaccine Study
11:26am, Wednesday, 14'th Oct 2020
Vaxart (VXRT) doses the first subject in an early-stage study of its oral coronavirus vaccine candidate VXA-CoV2-1. Stock rises.
Covid Report: Moderna Gets Key Ruling In Europe; Vaxart Tablet Passes 'Hamster Challenge'
09:41am, Wednesday, 14'th Oct 2020
Moderna advanced its Covld-19 vaccine approval process in Europe with a key ruling by regulators; Vaxart posted good results in hamsters for its pill vaccine; MRNA stock, VXRT stock rose. The post Cov
Covid-19 Vaccine In Pill Form? Vaxart Doses First Test Participants With Its Oral Tablet; Stock Jumps
11:13am, Tuesday, 13'th Oct 2020
Tiny biotech Vaxart has advanced into its first human tests for its tablet-form Covid-19 vaccine candidate, a Phase 1 clinical trial with up to 48 adult volunteers, and VXRT stock soared. The post Cov
